Come up with a name for your new list and we'll add to it:
AlphaGEN raised a round of funding on , . Investors include
Mitsubishi UFJ Capital.
The company are developing siRNA drugs targeting a control factor for HIF (hypoxia-inducible factor), which is one of the main factors involved in angiogenesis. The company have found that siRNA can p…